As of April 2024 Oncolytics Biotech has a market cap of $82.24 Million. This makes Oncolytics Biotech the world's 7508th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $82.24 M | -17.18% |
2023 | $99.31 M | 3.22% |
2022 | $96.21 M | 27.4% |
2021 | $75.52 M | -26.35% |
2020 | $0.10 B | -32.35% |
2019 | $0.15 B | 372.77% |
2018 | $32.06 M | -59.66% |
2017 | $79.49 M | 233.77% |
2016 | $23.81 M | -27.35% |
2015 | $32.77 M | -36.42% |
2014 | $51.55 M | -61.01% |
2013 | $0.13 B | -57.03% |
2012 | $0.30 B | 10.22% |
2011 | $0.27 B | -38.96% |
2010 | $0.45 B | 182.89% |
2009 | $0.16 B | 204.74% |
2008 | $53.04 M | -31.48% |
2007 | $77.41 M | -1.4% |
2006 | $78.51 M | -53.5% |
2005 | $0.16 B | 15.27% |
2004 | $0.14 B | 56.51% |
2003 | $93.59 M | 261.24% |
2002 | $25.9 M | -67.93% |
2001 | $80.79 M |
On Apr 25th, 2024 the market cap of Oncolytics Biotech was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | $698.56 B | 849,246.87% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $91.49 B | 111,147.37% | ๐บ๐ธ USA |
Mirati Therapeutics MRTX | $4.11 B | 4,906.44% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | $9.49 M | -88.45% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.80 B | 19,114.17% | ๐ฎ๐ฑ Israel |
AVEO Oncology
AVEO | $0.52 B | 534.00% | ๐บ๐ธ USA |